Therapeutic strategy for signet ring cell carcinoma of the stomach.
about
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challengeClinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomachDifferential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.Signet-ring cell carcinoma of the distal common bile duct: report of a caseSignet ring cell histology is not an independent predictor of poor prognosis after curative resection for gastric cancer: a propensity analysis by the KLASS Group.Prognostic significance of signet ring gastric cancer.Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types.Predictive factors for lymph node metastasis in signet ring cell gastric cancer and the feasibility of endoscopic submucosal dissection.The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients.A short guide to hereditary diffuse gastric cancer.Prognostic analysis of gastric gastrointestinal stromal tumor with synchronous gastric cancer.An evidence-based review of the surgical treatment of gastric adenocarcinoma.Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma.Is signet-ring cell carcinoma a specific entity among gastric cancers?Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.The Clinicopathological Features and Long-Term Survival Outcomes of Mucinous Gastric Carcinoma: a Consecutive Series of 244 Cases from a Single Institute.Prognostic Impact of Different Histological Types on Gastric Adenocarcinoma: a Surveillance, Epidemiology, and End Results Database Analysis.Prognostic factors of intraperitoneal chemotherapy for peritoneal carcinomatosis of gastric cancer: A retrospective study from a single center.Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis.The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination.Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study.The difference in clinic-pathological features between signet ring cell carcinoma and gastric mucinous adenocarcinoma.Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis.Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis.Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma.Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer.Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and Genotype
P2860
Q26777538-851B452A-1F78-42B2-B039-754DABB964C7Q30050395-B4B22BE0-7033-460F-9D27-70F2505AC482Q33557905-8DBC802F-80AD-4B3A-A418-050F3F8EF689Q34161984-BFA7858A-5B22-44F5-B73B-F36D5054E63AQ36152506-B3A8F553-23AC-4C02-90DE-4461EE50B3FCQ36267677-ABB98B29-1F13-4023-8D49-B46C4FEF0ADBQ36513148-BAA82EFB-D7D9-40CF-BCE5-BF77E23DC157Q36993485-E15060A4-8F7E-4E0D-BE76-C7718FED704BQ37327969-765EE70B-A140-4753-833A-7F60578EC266Q37331082-A939425A-EB51-4F2B-9DC8-A31829E85DADQ37568168-07657D5F-4F9F-47BA-BBAD-E641ECC93AE9Q37852579-28DB036D-287A-47CA-8997-AE7DB8B32834Q38176226-0056F1FB-6ED0-4A2E-8409-EF7F1B2E4F70Q38938637-73DC1E11-1F0D-4CFE-B52C-D3F248DA3087Q39373538-57F0AC7F-E5C5-4F54-9514-C7DA63A5E2AFQ40142812-EAA4DA3D-C476-48A0-B20E-7C438C535E4EQ40367234-9A0CE994-DB99-499E-B2E0-6F1CC7991B80Q40496581-F1CAC8FD-CB07-4AB8-8349-260D70245E28Q40528329-7090D31E-67BB-49AA-AEF5-D53F2F47A27DQ40756645-224452CC-2660-48D1-9119-26BFD2B39F00Q41834291-A72782A7-0002-44E4-860D-1167432D1FEFQ43871451-065341C4-C03F-4F63-A733-F89B45CB3AEEQ46843740-46B28719-6830-4997-9094-461E00F17A51Q47104067-D222904A-59CF-402E-B91D-C3EAF7E90F3AQ47331073-342E2065-1D27-402B-97A0-8EC352709D0FQ48337416-23F72B4C-757C-4CB6-BAE1-CD9C8868FC35Q51309590-15D98704-2B9D-4084-A469-C32F915CA449Q57493791-93264AE5-B781-431C-A039-F13A84C71AA6
P2860
Therapeutic strategy for signet ring cell carcinoma of the stomach.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@ast
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@en
type
label
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@ast
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@en
prefLabel
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@ast
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@en
P2093
P356
P1476
Therapeutic strategy for signet ring cell carcinoma of the stomach.
@en
P2093
P304
P356
10.1002/BJS.4637
P407
P577
2004-10-01T00:00:00Z